Kikuchiûs Disease : √“¬ß“πºŸâªÉ

Transcription

Kikuchiûs Disease : √“¬ß“πºŸâªÉ
90 «“√ “√»Ÿπ¬å°“√»÷°…“·æ∑¬»“ µ√å§≈‘π‘° ‚√ß欓∫“≈æ√–ª°‡°≈â“
ªï∑’Ë 23 ©∫—∫∑’Ë 2 ‡¡.¬. - ¡‘.¬. 2549
√“¬ß“πºŸªâ «É ¬
Kikuchiûs Disease : √“¬ß“πºŸâªÉ«¬Àπ÷Ëß√“¬∑’Ë¡“
¥â«¬µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ
«— ¥‘Ï ‡®’¬¡®‘µ æ.∫.*
Abstract
Kikuchiûs Disease Present with Cervical Lymphadenopathy : A Case Report
Sawat Jaemjit M.D.*
* Department Otolaryngology Maharat Naknon Ratchasima Hospital, Nakhonrachasima
province, Thailand.
J Prapokklao Hosp Clin Med Educat Center 2006;23:90-94.
Kikuchiûs disease, also known as Kikuchi-Fujimoto disease or histiocytic necrotizing
lymphadenitis that is a rare disease of cervical lymphadenitis. It mostly affects young Asian
women and is being increasingly recognized in worldwide. It resolves spontaneously, usually
over a period of several weeks to 3 months, rarely to 6 months. Cervical lymphadenopathy is
the most prominent symptom and should be differentiated from lymphoproliferative, autoimmune
and postinfectious diseases. A 37-year-old Thai woman with history of a left cervical mass
for 6 month was persented with Kikuchiûs disease at Nakornratchasima regional hospital.
∫∑π”
æ∫„π‡æ»À≠‘ß¡“°°«à“‡æ»™“¬ „π™à«ßÕ“¬ÿª≈“¬¬’Ë ‘∫
ªï∂÷ßµâπÕ“¬ÿ “¡ ‘∫ªï3 Õ“°“√· ¥ß¡“¥â«¬µàÕ¡πÈ”‡À≈◊Õß
∫√‘‡«≥§Õ‚µ ¡’ ‰¢â ÕàÕπ‡æ≈’¬ πÈ”Àπ—°≈¥ ª«¥µ“¡¢âÕ
¡â“¡‚µ ÕÕ°º◊Ëπ °“√¥”‡π‘π‚√§À“¬‰¥â‡Õß ‚¥¬„™â√–¬–
‡«≈“ 2-3 —ª¥“Àå ‰¡à‡°‘π 6 ‡¥◊Õπ Õ“°“√µàÕ¡πÈ”‡À≈◊Õß
∫√‘‡«≥§Õ‚µ¡—°®–‡ªìπÕ“°“√‡¥àπ ´÷Ëß∑”„ÀâµâÕß«‘π‘®©—¬
·¬°‚√§ÕÕ°®“°‚√§„π°≈ÿ à ¡ lymphoproliferative,
autoimmune, ·≈– postinfections
Kikuchiûs disease ‡ªìπ‚√§∑’√Ë ®âŸ °— ¥’„π°≈ÿ¡à 欓∏‘
·æ∑¬å·µà ”À√—∫∑“ß‚ µ »Õ π“ ‘° ¡’√“¬ß“πºŸâªÉ«¬
‡ªìπ§√—Èß·√°‡¡◊ËÕªï æ.». 2528 ‚¥¬ Gleeson ·≈–§≥–4
Kikuchiûs disease À√◊Õ Kikuchi-Fujimoto
disease À√◊Õ histiocytic necrotizing lymphadenitis
‡ªì π ‚√§∑’ Ë æ ∫‰¥â π â Õ ¬‚¥¬¡’ ° “√√“¬ß“π‡ªì π §√— È ß ·√°
æ√âÕ¡°—π∑’ªË √–‡∑»≠’ªË πÉÿ ªï æ.».1972 ‚¥¬‡ªìπ√“¬ß“π
¢Õß Kikuchi1 °—∫√“¬ß“π¢Õß Fujimoto ·≈–§≥–2
√“¬ß“πºŸâªÉ«¬ à«π„À≠à®–Õ¬Ÿà „π∑«’ª‡Õ‡™’¬ ‡™àπ ≠’˪ÿÉπ
‡°“À≈’ ŒàÕß°ß ªí®®ÿ∫—π ¡’√“¬ß“πæ∫°√–®“¬∑—Ë«‚≈°
“‡Àµÿ¢Õß‚√§¬—߉¡à∑√“∫·πà™—¥ ·µà¡’°“√ —ππ‘…∞“π«à“
¿“«–µ‘¥‡™◊ÈÕ parasite, bacteria, EBV À√◊Õ‚√§„π°≈ÿà¡
autoimmune Õ“®®–‡ªìπªí®®—¬∑’Ë∑”„À⇰‘¥‚√§‰¥â ¡—°
* °≈ÿà¡ß“π‚ µ »Õ π“ ‘°«‘∑¬“ ‚√ß欓∫“≈¡À“√“™π§√√“™ ’¡“ ®—ßÀ«—¥π§√√“™ ’¡“
Vol. 23 No. 2 Apr. - Jun. 2006
J Prapokklao Hosp Clin Med Educat Center 91
µàÕ¡“‡√‘Ë¡¡’√“¬ß“π°“√µ√«®æ∫‚√§‡æ‘Ë¡¢÷Èπ¡“‡√◊ËÕ¬ Ê histiocytes admixed with cellular debris and nuclear
”À√— ∫ ª√–‡∑»‰∑¬¡’ √ “¬ß“πºŸ â ª É « ¬ 1 √“¬‚¥¬ dust. ¥—ß√Ÿª
Fooanant S. ·≈–§≥–5 ‡π◊ÕË ß®“°ºŸªâ «É ¬∑’‡Ë ªìπ‚√§π’¡È °— ‰¥â
√—∫°“√«‘π‘®©—¬‚√§®“°°“√µ—¥µàÕ¡πÈ”‡À≈◊Õß (lymph
node biopsy) ∫√‘‡«≥§Õ‡æ◊ËÕµ√«®™‘Èπ‡π◊ÈÕ ¥—ßπ—Èπ·æ∑¬å
®÷ߧ«√µ√–Àπ—°·≈–√–≈÷°∂÷ß‚√§π’È ‰«â¥â«¬·¡â®–‡ªìπ‚√§∑’Ë
æ∫‰¥âπâÕ¬°Áµ“¡ √“¬ß“π©∫—∫π’È®÷ߢÕ𔇠πÕ√“¬ß“π
ºŸªâ «É ¬1 √“¬∑’¡Ë “¥â«¬Õ“°“√µàÕ¡πÈ”‡À≈◊Õß∫√‘‡«≥§Õ‚µ·≈–
‰¥â√—∫°“√«‘π‘®©—¬‡ªìπ Kikuchiûs disease
√“¬ß“πºŸªâ «É ¬
ºŸâªÉ«¬À≠‘߉∑¬Õ“¬ÿ 37 ªï Õ“™’æ√—∫®â“ß ∑’ËÕ¬Ÿà
®—ßÀ«—¥π§√√“™ ’¡“ ‰¥â‡¢â“√—∫°“√µ√«®√—°…“∑’Ë·ºπ° ÀŸ
§Õ ®¡Ÿ° ‚√ß欓∫“≈¡À“√“™ ®—ßÀ«—¥π§√√“™ ’¡“
‡¡◊ËÕ‡¥◊Õπ°ÿ¡¿“æ—π∏å æ.». 2548 ¥â«¬Õ“°“√¡’°âÕπ∑’˧Õ
¢â“ߴ⓬¡“ª√–¡“≥ 6 ‡¥◊Õπ ºŸâªÉ«¬‰¡à¡’Õ“°“√‡®Á∫
∫√‘‡«≥°âÕπ ‰¡à¡’ ‰¢â πÈ”Àπ—°§ß∑’Ë ‰¡à¡’Õ“°“√√à«¡Õ◊Ëπ Ê
µ√«®√à“ß°“¬æ∫°âÕπ¢π“¥
‡ âπºà“π»Ÿπ¬å°≈“ß 1.5 ‡´πµ‘‡¡µ√ ∑’Ë∫√‘‡«≥
posterior triangle ¢Õߧեâ“π´â“¬°âÕπ¡’≈—°…≥– firm,
movable, not tender, smooth surface µ√«®
√à“ß°“¬„π‚æ√ß®¡Ÿ°
À≈—ß‚æ√ß®¡Ÿ° „π™àÕߪ“° ™àÕß§Õ ·≈–°≈àÕß
‡ ’¬ß ‰¡àæ∫§«“¡º‘¥ª°µ‘Õ◊Ëπ Ê
º≈µ√«®∑“ßÀâÕߪؑ∫µ— °‘ “√ CBC æ∫ Hct 39.6%
WBC 10,000 (NE 65%, LY 21 %, MO 7 %) Plt 362,000
·≈– Anti HIV - ve À≈—ß®“°ºŸâªÉ«¬‰¥â√—∫¬“ªØ‘™’«π–
cloxacillin 500 mg. «—π≈– 4 §√—Èß π“π 2 —ª¥“Àå æ∫«à“
°âÕπ‰¡à¬ÿ∫≈ß ®÷߇¢â“√—∫°“√ºà“µ—¥°âÕπ (excision biopsy)
‡æ◊ËÕµ√«®∑“ß欓∏‘«‘∑¬“ °âÕπµàÕ¡πÈ”‡À≈◊Õß¡’≈—°…≥–
∑“ß®ÿ≈欓∏‘«‘∑¬“ §◊Õ
The lymph node architecture is partially
maintained and residual follicles show reactive
germinal centers. Geographic large areas of necrosis
is seen. The necrosis consists of nuclear fragments
surrounded by large accumulations of palely staining
°“√«‘π‘®©—¬§◊Õ acute necrotizing histiocytic
lymphadenitis À√◊Õ Kikuchiûs disease ¿“¬À≈—ß®“°
ºà“µ—¥°âÕπ·≈–µ√«®µ‘¥µ“¡ºŸâªÉ«¬π“π 6 ‡¥◊Õπ (®π∂÷ß
¢≥–π’È) æ∫«à“≈—°…≥–∫“¥·º≈À“¬‡ªìπª°µ‘¥’ ‰¡à¡’°âÕπ
·≈–ºŸâªÉ«¬‰¡à¡’Õ“°“√º‘¥ª°µ‘·µàÕ¬à“ß„¥
«‘®“√≥å
Kikuchiûs disease ‡ªìπ‚√§∑’Ëæ∫∫àÕ¬„π∑«’ª
‡Õ‡™’¬„πÕ—µ√“‡æ»À≠‘ßµàՇ滙“¬‚¥¬ª√–¡“≥ 3-4: 16
‚¥¬¡—°®–æ∫„π™à«ßÕ“¬ÿª≈“¬¬’Ë ‘∫ªï∂÷ßµâπÕ“¬ÿÀâ“ ‘∫ªï
(Õ“¬ÿ‡©≈’ˬ 30 ªï) æ∫¡“°„πª√–‡∑»≠’˪ÿÉπ·≈–‡ªìπ
ª√–‡∑»·√°∑’Ë¡’√“¬ß“πæ∫ºŸâªÉ«¬ µàÕ¡“®÷ß¡’√“¬ß“π
°“√µ√«®æ∫‚√§™π‘¥π’È„πª√–‡∑»Õ◊Ëπ Ê ∑—Ë«‚≈°
“‡Àµÿ¢Õß°“√‡°‘¥‚√§¬—߉¡à∑√“∫·πà™¥— ‰¡àæ∫
«à“æ—π∏ÿ°√√¡À√◊Õ ¿“æ·«¥≈âÕ¡‡ªìπªí®®—¬„À⇰‘¥‚√§∑’Ë
™—¥‡®π·µà¡’¢âÕ —ππ‘∞“π«à“Õ“®¡’ “‡Àµÿ®“°°“√µ‘¥‡™◊ÈÕ
µà“ß Ê7 ‡™àπ ¿“«–°“√µ‘¥‡™◊ÈÕ®“°‰«√— ( rubella virus,
paramyxovirus ·≈–parainfluenza virus ) À√◊Õ °“√
µ‘¥‡™◊ÈÕ®“°ª“√“ ‘µ (toxoplasma) ·≈–°“√µ‘¥‡™◊ÈÕ®“°
·∫§∑’‡√’¬ (Yersinia enterocolitica)3,7
Õ“°“√·≈–Õ“°“√· ¥ß ¡“°°«à“À√◊Õ‡∑à“°—∫
√â Õ ¬≈– 80 3,6,7,8,9 ¢ÕߺŸ â ª É « ¬¡— ° ®–¡“æ∫·æ∑¬å ¥ â « ¬
Õ“°“√µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ ‰¡à¡’Õ“°“√‡®Á∫∑’Ë°âÕπ8
À√◊Õ‡®Á∫πâÕ¬ (mild tender)3 ‚¥¬ºŸâªÉ«¬∑’Ë¡’°âÕπµàÕ¡πÈ”
‡À≈◊Õß∑’˧Ղµ¡—°æ∫∑’Ë∫√‘‡«≥ posterior triangle √âÕ¬≈–
65-70 ·≈–æ∫∫√‘‡«≥Õ◊Ëπ Ê ‰¥âπâÕ¬ ‡™àπ axillary node
92 «“√ “√»Ÿπ¬å°“√»÷°…“·æ∑¬»“ µ√å§≈‘π‘° ‚√ß欓∫“≈æ√–ª°‡°≈â“
√âÕ¬≈– 149 À√◊Õ supraclavicular node √âÕ¬≈– 129
„π®”π«ππ’È√âÕ¬≈– 79 ‡ªìπºŸâªÉ«¬∑’Ë¡’°âÕπµàÕ¡πÈ”‡À≈◊Õß
‚µ¢â“߇¥’¬« (unilateral cervical) à«π∑’ˇÀ≈◊Õ√âÕ¬≈– 21
‡ªìπºŸâªÉ«¬∑’Ëæ∫°âÕπ‚µ∑—Èß Õߢâ“ß (bilateral cervical)
¢π“¥¢Õß°âÕπ à«π„À≠àæ∫‰¥âµ—Èß·µà 1-4 ´¡.·µàÕ“®æ∫
°âÕπ‚µ¢π“¥ 5-6 ´¡.‰¥â „π∫“ß√“¬6 πÕ°®“°π’ÈÕ“®æ∫
Õ“°“√Õ◊ËπÊ√à«¡¥â«¬‡™àπ ¡’ ‰¢â µ—∫¡â“¡‚µ ª«¥»’√…–
§≈◊Ëπ‰ â Õ“‡®’¬π º◊Ëπ∑’˺‘«Àπ—ß ª«¥¢âÕ ·≈–Õ◊Ëπ Ê
Kikuchiûs disease ¡’§«“¡ —¡æ—π∏å°—∫‚√§
SLE ‚¥¬Õ“®®–«‘π‘®©—¬‡ªìπ‚√§‰¥âæ√âÕ¡°—πµ—Èß·µà‡√‘Ë¡µâπ
À√◊Õ¿“¬À≈—ß®“°«‘π‘®©—¬‚√§ Kikuchiûs disease ·≈â«
®÷ßµ√«®æ∫‚√§ SLE ´÷ËßÕ“®„™â√–¬–‡«≈“µ—Èß·µà 10 ‡¥◊Õπ
∂÷ß 3 ªï10 ¥—ßπ—Èπ®÷ߧ«√¡’°“√µ‘¥µ“¡°“√√—°…“ºŸâªÉ«¬„π
√–¬–¬“« ·≈–‡ΩÑ“√–«—ß°“√‡°‘¥‚√§ SLE √à«¡¥â«¬
°“√«‘π®‘ ©—¬·¬°‚√§ ‡π◊ÕË ß®“°ºŸªâ «É ¬¡—°®–¡“¥â«¬
Õ“°“√¡’µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ °“√«‘π‘®©—¬·¬°‚√§¡—°®–
Õ¬Ÿà „π°≈ÿà¡‚√§¥—ßµàÕ‰ªπ’È
1. °“√µ‘¥‡™◊ÕÈ ( infection) ‡™à𠉫√— ·∫§∑’‡√’¬
ª“√“ ‘µ
2. Autoimmune ‡™àπ SLE
3. Malignant ‡™àπ lymphoma ‡π◊ËÕß®“°
Kikuchiûs disease ¡—°‰¥â√—∫°“√«‘π‘®©—¬‚√§º‘¥‡ªìπ
lymphoma ‰¥â∂÷ß√âÕ¬≈– 408, metastatic carcinoma
°“√µ√«®∑“ßÀâÕߪؑ∫—µ‘°“√‰¡à “¡“√∂¬◊π¬—π
°“√«‘π‘®©—¬‰¥â ·µà™à«¬„π°“√«‘π‘®©—¬·¬°‚√§Õ◊Ëπ11 ‡™àπ
SLE ºŸâªÉ«¬¥â«¬‚√§ Kikuchi ª√–¡“≥√âÕ¬≈– 503 ¡—°æ∫
¿“«–‡¡Á¥‡≈◊Õ¥¢“«µË”‡≈Á°πâÕ¬ (mild granulocytopenia)
·≈–Õ“®®–æ∫§à“ ESR ·≈– C- reactive protein Ÿß3
πÕ°®“°π—Èπ°“√∑” fine needle aspiration
(FNA) ¢ÕßµàÕ¡πÈ”‡À≈◊Õß Õ“®®–™à«¬„π°“√ π—∫ πÿπ
°“√«‘π‘®©—¬ (suggest) ·µà ‰¡à “¡“√∂„™â „π°“√«‘π‘®©—¬
‚√§‰¥âÕ¬à“߉√ °Áµ“¡≈—°…≥–®”‡æ“– (typical finding)
∑’Ëæ∫‰¥â „π°“√µ√«® fine needle aspiration 3 §◊Õ
lymphocytes (small and atypical), reactive
phagocytic histiocytes, and çintense extracellular
debrisé
ªï∑’Ë 23 ©∫—∫∑’Ë 2 ‡¡.¬. - ¡‘.¬. 2549
”À√—∫ definite diagnosis ¢Õß‚√§ Kikuchiûs
„™â«‘∏’°“√µ—¥°âÕπµàÕ¡πÈ”‡À≈◊Õß (lymph node biopsy)
¡“µ√«®®ÿ≈欓∏‘«‘∑¬“ (histopathology) ´÷Ëß®–æ∫
欓∏‘ ¿“æ histopathology ‰¥â 3 ≈—°…≥– §◊Õ
proliferative, necrotizing ·≈– xanthomatous3,12 ´÷Ëß®–
µâÕßæ∫¢âÕ∫àß™’È (critiria)6 µ“¡≈—°…≥–µàÕ‰ªπ’È
1. patchy irregular areas of eosinophilic
necrosis in the paracortex and/or cortex
2. pronounced fragments of nuclear dust
distributed in an irregular fashion through the area
of necrosis
3. absence of granulocytes and paucity of
plasma cells
4. clusters of plasmacytoid T cells, or
plasmacytoid monocytes, and
5. numerous immunoblasts ( transformed
lymphocytes, predominantly of T cell phenotype).
à«π„À≠ຟâªÉ«¬∑’ˇªìπ‚√§ Kikuchiûs ®–¡’Õ“°“√
¥’¢÷Èπ¿“¬„π 2-3 —ª¥“Àå ·≈–À“¬‰¥â‡Õß (self limited
disease) ‚¥¬√–¬–‡«≈“°“√¥”‡π‘π‚√§‰¡à‡°‘π 6 ‡¥◊Õπ3
·≈–‰¡àµâÕß°“√°“√√—°…“∑’Ë®”‡æ“– À≈—°¢Õß°“√√—°…“
‚√§„™â«‘∏’°“√√—°…“·∫∫ª√–§—∫ª√–§Õß (supportive)
‚¥¬°“√„™â¬“„π°≈ÿà¡ nonsteroidal anti- inflammatory
drug9 ¬°‡«âπ„π√“¬∑’Ë¡’ªí≠À“À√◊Õæ∫√à«¡°—∫‚√§Õ◊Ëπ Ê
‡™àπ SLE ´÷Ëß®–„À⬓„π°≈ÿà¡ corticosteroid6 Õ¬à“߉√
°Áµ“¡¡’ºŸâªÉ«¬∫“ß√“¬∑’Ë¡’Õ“°“√π“π‰ª°«à“π’È ‰¥â ®÷ß¡’
√“¬ß“π∫“ß©∫—∫‡ πÕ„Àℙ⫑∏’ excision biopsy ‡æ◊ËÕ
µ—¥°âÕπ∑’Ë¡’欓∏‘ ¿“æÕÕ° ´÷Ëß®–™à«¬∑”„À⺟âªÉ«¬À“¬
®“°‚√§‰¥â‡√Á«¬‘Ëߢ÷Èπ8,9
°“√°≈—∫‡ªìπ´È” (recurrence of the disease)
æ∫ºŸâªÉ«¬√âÕ¬≈– 3.310,12 °≈—∫¡“‡ªìπ‚√§π’ȴȔՒ°¿“¬„π
√–¬–‡«≈“ 4-7 ªï À≈—ß®“°°“√«‘π‘®©—¬‚√§§√—Èß·√°
‚¥¬„π°≈ÿà¡∑’Ë°≈—∫¡“‡ªìπ‚√§´È”Õ’°√âÕ¬≈– 80 æ∫°âÕπ
µàÕ¡πÈ”‡À≈◊Õ߬ÿ∫À“¬‰¥â‡Õß¿“¬„π 6 ‡¥◊Õπ ‚¥¬‰¡à ‰¥â√—∫
°“√√—°…“„¥ Ê
¡’√“¬ß“πæ∫ºŸâªÉ«¬ Kikuchiûs ‡ ’¬™’«‘µ 2 √“¬
Vol. 23 No. 2 Apr. - Jun. 2006
‚¥¬ºŸâªÉ«¬ 1 √“¬ “‡Àµÿ°“√µ“¬‡π◊ËÕß®“° lupus-like
syndrome13 √“¬∑’Ë 2 “‡Àµÿ°“√µ“¬‡π◊ËÕß®“°À—«„®
≈⡇À≈«·∫∫‡©’¬∫æ≈—π (sudden heart failure)¿“¬
À≈—ß®“°°“√µ—¥°âÕπµàÕ¡πÈ”‡À≈◊Õß∑’˧ա“µ√«®‰¥â‡æ’¬ß
72 ™¡.14
√ÿª
‚√§ Kikuchiûs ‡ªìπ‚√§∑’Ëæ∫‰¥âπâÕ¬·≈–‡ªìπ
‚√§∑’ËÀ“¬‰¥â‡Õß¿“¬„π√–¬–‡«≈“ª√–¡“≥ 6 ‡¥◊Õπ
‡ªìπ‚√§∑’Ë¡’§«“¡ ”§—≠∑’Ë®–µâÕß«‘π‘®©—¬·¬°‚√§Õ◊Ëπ Ê ∑’Ë
‡ªìπÕ—πµ√“¬∑’Ë∑”„À⇰‘¥µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ ‡π◊ËÕß®“°
°“√¥”‡π‘π‚√§·≈–°“√√—°…“¡’§«“¡·µ°µà“ß°—π‡ªìπ
Õ¬à“ß¡“°°—∫‚√§Õ◊ËπÊ ‚¥¬°“√∑” excision biopsy „π
√“¬∑’Ë¡’µàÕ¡πÈ”‡À≈◊Õß‚µπ“π°«à“ Õß —ª¥“Àå
Referrences
1. Kikuchi M. Lymphadenitis showing focal
reticulum cell hyperplasia with nuclear debris
and phagocytes : a clinicopathological stuty.
Nippon Ketsueki Gakkai Zasshi 1972;35:
379-80.
2. Fujimoto Y,Kojima Y, Yamaguchi K. Cervical
subacute necrotizing lymphadenitis. Naika
1972;30:920-7.
3. Baumgartner BJ, Helling ER. Kikuchiûs disease:
a case report and review of the literature. ENTJ
2002;81:331-5.
4. Gleeson MJ,Siodlak MZ, Barbatis C, Salama
NY. Kikuchiûs disdase-: a new cause of
cervical lymphadenopathy. J Laryngol Otol
1985;99:935-9.
J Prapokklao Hosp Clin Med Educat Center 93
5. Fooanant S, Sriuthaisiriwong P, Kanchanarak
C, Hanprasertpong J, Chaiwan B.Kikuchiûs
disease presented with lateral neck cellutis,
parotidomegaly and enlargement of
sternocleidomastoid muscle. ‡Õ° “√°“√
ª√–™ÿ¡«‘™“°“√√“™«‘∑¬“≈—¬‚ µ »Õ π“ ‘° ·æ∑¬å
·Ààߪ√–‡∑»‰∑¬ ª√–®”ªï 2/2547.
6. Lin HC, Su CY, Huang CC, Hwang CF, Chien
CY. Kikuchiûs disease : a review and analysis
of 61 cases Otolaryngol Head Neck Surg ªï
;128:650-3.
7. Yu HL, Lee SSJ, Tsai HC, HuangCK, Chen
YS, Lin HH, et al. Clinical manifestations of
Kikuchi, s disease in southern Taiwan.
Microbiol Immunal Infect 2005;38-40.
8. Ramirez AL, Johnson J, Murr AH, KikuchiFujimotoûs disease : an easily misdiagnosed
clinical entity Otolaryngol Head Neck Surg
2001;651-3.
9. Garcia CE, Girdhad-Gopad HV, Dofman
DM.Kikuchi-Fujimoto disease of the neck :
update : Update. Ann Oto Rhino Laryngol
1993;102:11-5.
10. Wang TJ, YANG YH, Lin YT, Chiang BL.
Kikuchi-Fujimoto disease in children : clinical
features and disease course. J Microbiol
Immunal Infect 2004;37:219-24.
11. Koybasi S, Saydam L, Gungen Y, Histiocytic
necrotizing lymphadenitis of the eck.Am J
Otolaryngol 2003;24:344-7.
12. Kuo TT. Kikuchiûs disease (histiotycite)
necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of
histologic subtypes, immunohistology, and
ploidy. Am J Surg Pathol 1995;19:798-809.
94 «“√ “√»Ÿπ¬å°“√»÷°…“·æ∑¬»“ µ√å§≈‘π‘° ‚√ß欓∫“≈æ√–ª°‡°≈â“
13. Chan JK, Wong KC, Ng CS. A fatal case of
multicentric Kikuchiûs histiocytic necrotizing
lymphadenitis. Cancer 1989;63:1856-62.
14. Lin SH, Ko WS, Lee HS, Hwang WS.
Kikuchiûs disease associated with lupus like
syndrome-a fatal case [letter]. J Rheumatol
1992;19:1995-6.
ªï∑’Ë 23 ©∫—∫∑’Ë 2 ‡¡.¬. - ¡‘.¬. 2549

Documents pareils

How Experts Do It Unimproved GERD After PPI Treatment

How Experts Do It Unimproved GERD After PPI Treatment μÕ∫ æ∫‰¥â§Õà π¢â“ß∫àÕ¬ ∂ⓇªìπºŸªâ «É ¬∑’¡Ë “¥â«¬Õ“°“√ heartburn, regurgitation ¡—°μÕ∫ πÕßμàÕ PPI ¥’ ·μà∑’ˉ¡àμÕ∫ πÕß¡—°‡ªìπæ«°∑’Ë¡’Õ“°“√∑“ß ENT À√◊Õ¡’ ·§àÕ“°“√≈¡μ’¢÷ÈπÕ°À√◊Õ§Õ ·μà∂Ÿ°«‘π‘®©—¬º‘¥«à...

Plus en détail

4 Single femoral

4 Single femoral ‡¡◊ËÕ‡ª√’¬∫‡∑’¬∫º≈°“√∑” FNB μàÕ°“√‡ √‘¡§«“¡  “¡“√∂„π°“√√–ß—∫ª«¥„π√–¬–À≈—ß°“√ºà“μ—¥ ‚¥¬‡©æ“–„π 24 ™—Ë«‚¡ß·√°À≈—ß°“√ºà“μ—¥ ®“°°“√»÷°…“π’ȉ¡àæ∫«à“ºŸâªÉ«¬ ∑—Èß 2 °≈ÿà¡ μâÕß°“√¬“°≈ÿà¡ opioids ‡æ‘Ë¡‡μ‘¡„...

Plus en détail

Unilateral Blindness as a First Sign of Bronchogenic Carcinoma

Unilateral Blindness as a First Sign of Bronchogenic Carcinoma patients, especially who have another neurologic deficits or known cancer should bring to mind the diagnosis of meningeal carcinomatosis. Thai J Ophthalmol 2008; January-June 22(1): 77-81.

Plus en détail

π«∑“ß°“√«`π`

π«∑“ß°“√«`π` amination §«√∑”°“√µ—¥™‘Èπ‡π◊ÈÕ‡æ◊ËÕ àßµ√«® histology ∑ÿ°√“¬ 17. À≈—°°“√√—°…“‡À¡◊Õπ„π¢âÕ 13 [LSM/Intensify treatment (1)] ·µà ∂⓺ŸâªÉ«¬Õ“°“√¬—߉¡à¥’¢÷Èπ¢π“¥¢Õß H2RA Õ“®‡æ‘Ë¡‡ªìπ 2 ‡∑à“‰¥â ‡™àπ „Àâ ...

Plus en détail

§≈`π`°æàÕ ·¡à§ π‡°àß „π‚√ß欓∫“≈ àß ‡ √`¡ ÿ¢ ¿“æ ®.™≈∫ÿ√`

§≈`π`°æàÕ ·¡à§ π‡°àß „π‚√ß欓∫“≈ àß ‡ √`¡ ÿ¢ ¿“æ ®.™≈∫ÿ√` ·¡à·≈–‡¥Á°µ—Èß·µà°“√Ω“°§√√¿å®π∂÷ß°“√§≈Õ¥ ¥—ß ¢âÕ¡Ÿ≈Õπ“¡—¬·¡à·≈–‡¥Á°ª√–‡∑»‰∑¬ªïæ.». 2545 æ∫ Õ—µ√“ à«π°“√µ“¬¢Õß¡“√¥“ 22.1:100,000 °“√‡°‘¥¡’ ™’æ Õ—µ√“°“√µ“¬ª√‘°”‡π‘¥ 9.2:1000 °“√‡°‘¥∑—ÈßÀ¡¥ Õ—µ√“°“√¢“...

Plus en détail

7 ¿“«–æ`… ª“π„®

7 ¿“«–æ`… ª“π„® ‰¡‚§√°√—¡μàÕ™—Ë«‚¡ß ª–∫√‘‡«≥º‘«Àπ—ß∑ÿ° 72 ™—Ë«‚¡ß ¥—ßπ—Èπ ®÷ß„Àâ‡æ‘Ë¡ transdermal fentanyl ‡ªìπ¢π“¥ 50 ‰¡‚§√°√—¡μàÕ ™—Ë«‚¡ß √à«¡°—∫„À⬓‡ √‘¡ pregabalin 75 ¡‘≈≈‘°√—¡ ·≈– nortriptyline 10 ¡‘≈≈‘°√—¡ ...

Plus en détail